Grace M. Rhodes

Statistics

Publications

Citations

148

H-Index

Active since

2023

Affiliations

Eli Lilly (United States)(Current)

Monash University

Grace M. Rhodes is an author at Eli Lilly (United States) specializing in clinical pharmacology, pharmacotherapy, and culprit lesion revascularization.

Publications per year

2023–2024

Publications

Oral Muvalaplin for Lowering of Lipoprotein(a)

Stephen J. Nicholls, Wei Ni, Grace M. Rhodes et al. · JAMA · 2024 · 112 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial

Kreton Mavromatis, Philip G. Jones, Ziad A. Ali et al. · Journal of the American College of Cardiology · 2023 · 25 citations · Full text

Medicine, Cardiology, Surgery +13

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin

Craig Swearingen, John H. Sloan, Grace M. Rhodes et al. · Journal of Lipid Research · 2024 · 11 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +14

1–3 of 3